Re-stoking the therapy pipeline: How to stimulate the development of new antibiotics, diagnostics and novel therapies

Published: 20-Aug-2014

5 February 2015

Roundtable three

Wellcome Trust, London, UK


There are two sessions at this third roundtable. The first in on improving the identification and prioritisation of antimicrobial research; while the second will look at developing new drugs, treatments and diagnostics.

Organiser: The British Society for Antimicrobial Chemotherapy

http://bsac.org.uk/events/forthcoming-events/the-uk-antimicrobial-resistance-roundtable-series/

Trending Articles

  1. HEFMA Leadership Forum 8–10 May 2024 | Conference, exhibition and awards | Telford, UK
  2. Cleanroom Technology Conference UK 22–23 May 2024 | Conference and Exhibition | Birmingham, UK
  3. Design in Mental Health 4–5 June 2024 | Conference, Exhibition, Awards | Manchester, UK
  4. GIANT Health 9-10 December 2024 | Hybrid Conference | London, UK
  5. Healthcare Estates 8–9 October 2023 | Conference, Exhibition, Awards | Manchester, UK

You may also like

Hi Tech Manufacturing

£10m research competition to tackle antimicrobial resistance

Move aims to encourage the development of innovative scientific approaches to addressing antimicrobial resistance
Infection Control

Re-stoking the therapy pipeline: How to stimulate the development of new antibiotics, diagnostics and novel therapies

5 February 2015, Roundtable three, Wellcome Trust, London, UK
Infection Control

Safeguarding the effectiveness of existing antimicrobial treatments for serious infections

9 December 2014, Roundtable two, Wellcome Trust, London, UK
Infection Control

Improving knowledge and understanding of antimicrobial resistance

24 September 2014, Roundtable, Wellcome Trust, London, UK
Subscribe now